© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

SRI

Top section

Top section

Transition finance in transition — companies face investors in flux

Demand to invest in the low carbon transition is growing fast, but strategies are very diverse
Issuance net of buy-backs is not that high, and there is no sign of any indigestion

Caffil lands social covered bond as market ‘comes off the boil’

◆ Order book smaller than issuer’s last covered in January ◆ Banker said covered bond market has reached plateau ◆

AI impact fear rocks IPO hopefuls

Questions hang over the future of software as a service firms
Issuance net of buy-backs is not that high, and there is no sign of any indigestion
Sub-sections
  • Italy did not set the world alight with the sale of its first government bond targeted exclusively to retail investors. The proceeds will be used to finance measures related to Italy's post-Covid-19 economic recovery.
  • Gland Pharma, a subsidiary of Shanghai Fosun Pharmaceutical Group, has filed preliminary IPO documents with India’s securities regulator for a listing.
  • Funding officials from Caffil, Credit Mutuel Arkéa and La Banque Postale gathered in early July to take part in a roundtable to discuss how they navigated their way through the peak of the crisis when covered bond market volatility was at its highest, and how they expect to manage funding in its aftermath, as the pernicious impact of the pandemic takes its toll.